Jaroslaw P Maciejewski
Overview
Explore the profile of Jaroslaw P Maciejewski including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
367
Citations
11852
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Kawashima N, Kubota Y, Bravo-Perez C, Guarnera L, Williams N, Durmaz A, et al.
J Hematol Oncol
. 2024 Sep;
17(1):87.
PMID: 39334207
DNA methyltransferase 3 A mutations (DNMT3A) are frequent in myeloid neoplasia (MN) and mostly heterozygous. However, cases with multiple DNMT3A can be also encountered but their clinical and genetic landscape...
12.
Travaglini S, Silvestrini G, Attardi E, Fanciulli M, Scalera S, Antonelli S, et al.
Leuk Res
. 2024 Aug;
145:107568.
PMID: 39180902
Acute myeloid leukemia (AML) with inv(16) is typically associated with a favourable prognosis. However, up to 40 % of patients will eventually experience disease relapse. Herein, we dissected the genomic...
13.
Gordon J, Bravo-Perez C, Guarnera L, Unlu S, Kawashima N, Ahmed A, et al.
Blood Cancer J
. 2024 Jul;
14(1):125.
PMID: 39080258
No abstract available.
14.
Montoro M, Palomo L, Haferlach C, Acha P, Chan O, Navarro V, et al.
Blood
. 2024 Jul;
144(16):1722-1731.
PMID: 39074355
Mutations in the TP53 gene, particularly multihit alterations, have been associated with unfavorable clinical features and prognosis in patients diagnosed with myelodysplastic syndrome (MDS). Despite this, the role of TP53...
15.
Kewan T, Bahaj W, Gurnari C, Ogbue O, Mukherjee S, Advani A, et al.
Leukemia
. 2024 Jul;
38(9):2032-2036.
PMID: 39020062
No abstract available.
16.
Ogbue O, Kewan T, Bravo-Perez C, Unlu S, Kawashima N, Williams N, et al.
Leukemia
. 2024 Jul;
38(8):1839-1842.
PMID: 38982262
No abstract available.
17.
Yuan X, Kazemi Sabzvar M, Patil A, Chinnaswamy K, Howie K, Andhavaram R, et al.
Res Sq
. 2024 Jun;
PMID: 38883705
Mutations in RNA splicing factor genes including , , and have been reported to contribute to development of myeloid neoplasms including myelodysplastic syndrome (MDS) and secondary acute myeloid leukemia (sAML)....
18.
Rathje K, Gagelmann N, Salit R, Schroeder T, Gurnari C, Pagliuca S, et al.
Bone Marrow Transplant
. 2024 May;
59(8):1154-1160.
PMID: 38773281
Acute and chronic graft-versus-host disease (GvHD) are major complications of allogeneic hematopoietic cell transplantation (alloHCT). In vivo T-cell depletion with anti-T-lymphocyte globulin (ATLG) as part of the conditioning regimen prior...
19.
Awada H, Durmaz A, Kewan T, Ullah F, Dima D, Awada H, et al.
Leukemia
. 2024 May;
38(6):1411-1414.
PMID: 38734787
No abstract available.
20.
Tentori C, Gregorio C, Robin M, Gagelmann N, Gurnari C, Ball S, et al.
J Clin Oncol
. 2024 May;
42(24):2873-2886.
PMID: 38723212
Purpose: Allogeneic hematopoietic stem-cell transplantation (HSCT) is the only potentially curative treatment for patients with myelodysplastic syndromes (MDS). Several issues must be considered when evaluating the benefits and risks of...